RAC 0.93% $1.62 race oncology ltd

Ann: Change in substantial holding, page-76

  1. 5,722 Posts.
    lightbulb Created with Sketch. 1827
    Wow ... I read the (DrT about DrG selling) post before it was moderated.

    DrM ... gone, DrA ...gone, DrG (who received his RAC shares in return for the rights to bisantrene) marginalized ... it seems ... certainly talk like that will not help the cause IMO.

    I'd like to know if there are any implications (for bisantrene commercially) expected from CoH's brequinar S2 trial results expected in June?

    https://clinicaltrials.gov/ct2/show/NCT03760666

    And ... whether there is any IP associated with CoH related to their discovery about the action of bisantrene vis a vis FTO?

    https://www.cityofhope.org/news/powerful-small-molecules-may-be-able-to-kill-cancers


    This is a genuine post - no hidden agenda - had so much hope for RAC yet good people keep selling.
    Last edited by EWexplorer: 16/03/21
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.